# Study Of 90mg Of GW274150 In Subjects Over 50 Years, Who Have Rheumatoid Arthritis (RA)

> **NCT00370435** · PHASE2 · COMPLETED · sponsor: **GlaxoSmithKline** · enrollment: 6 (actual)

## Conditions studied

- Arthritis, Rheumatoid

## Interventions

- **DRUG:** GW274150

## Key facts

- **NCT ID:** NCT00370435
- **Lead sponsor:** GlaxoSmithKline
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2005-08
- **Primary completion:** 2005-09
- **Final completion:** 2005-09
- **Target enrollment:** 6 (ACTUAL)
- **Last updated:** 2017-05-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00370435

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00370435, "Study Of 90mg Of GW274150 In Subjects Over 50 Years, Who Have Rheumatoid Arthritis (RA)". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT00370435. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*